BSX

Q: What is the price of Boston Scientific (BSX) today?

A cotação de Boston Scientific (BSX) hoje está em $ 53.93, com uma variação de The stock began the year trading around $ 95.35 and is currently priced at $ 53.93. negociando na casa dos $ 95.35 e hoje está em $ 53.93. Acompanhe o and track broader market trends directly on the platform.

Q: When does Boston Scientific (BSX) pay dividends?

Boston Scientific (BSX) did not pay dividends over the past year.

Q: Is Boston Scientific (BSX) a good investment?

Atualmente, Boston Scientific (BSX) está cotada a $ 53.93, com um P/L de 22.46, This represents a 5,823% premium compared to its historical average P/E. uma variação de -47.57 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -47.57%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Boston Scientific Corp.

Price

$ 53.93

return (12m)

-47.57%

p/e

22.46

p/bv

0.00

DIVIDEND YIELD

0.00%

BSX price

BSX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BSX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-12.72%

3 months

-27.24%

1 year

-47.57%

2 years

-26.82%

5 years

30.42%

10 years

141.30%

Fundamentals BSX

review the fundamentals of Boston Scientific shares

P/E

22.46

Sector: -236.86 Industry: 1.11

P/S (PSR)

3.88

Sector: 1.41 Industry: 2.48

P/BV

0.00

Sector: 0.44 Industry: 2.27

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.00%

Sector: -172.33% Industry: -24.38%

ROE

0.00%

Sector: -398.12% Industry: -31.44%

ROIC

11.49%

Sector: -428.36% Industry: -81.70%

NET MARGIN

17.29%

Sector: -51.44% Industry: -31.09%

GROSS MARGIN

69.11%

Sector: 27.46% Industry: 51.18%

OPERATING MARGIN

19.92%

Sector: -47.58% Industry: -27.87%

EV/EBITDA

15.64

Sector: -221.25 Industry: 1.15

EV/EBIT

19.54

Sector: -229.16 Industry: -0.08

PRICE-TO-ASSETS

Sector: 0.72 Industry: 1.21

BVPS

Sector: -2.82 Industry: 4.85

EPS

2.40

Sector: -9,587.37 Industry: -0.70

EQUITY-TO-ASSETS RATIO

Sector: -0.01 Industry: 0.45

LIABILITIES / ASSETS

Sector: 0.30 Industry: 0.50

CAGR REVENUE 5 YEARS

11.64%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

27.92%

Sector: - Industry: -

Fundamentals BSX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	33.59	27.21	81.01%	0.66%	$ 848.86 B	34.98%
ISRG	53.63	9.08	16.93%	0.00%	$ 159.77 B	28.15%
TMO	25.26	3.32	13.15%	0.38%	$ 172.98 B	15.15%
SNY	11.59	1.26	10.86%	5.11%	$ 105.72 B	18.68%
NVS	20.60	7.16	34.77%	2.12%	$ 278.77 B	23.92%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	21.18	1.99	9.38%	3.73%	$ 97.70 B	13.00%
GSK	12.93	4.37	33.77%	3.48%	$ 101.42 B	17.79%
CVS	39.31	1.48	3.78%	2.94%	$ 115.27 B	0.72%
TMDX	13.42	4.67	34.80%	0.00%	$ 2.31 B	27.04%
HCA	14.35	-32.73	-228.14%	0.68%	$ 97.48 B	8.89%
IDXX	40.91	28.80	70.38%	0.00%	$ 44.81 B	24.63%
RMD	19.73	4.62	23.41%	1.13%	$ 29.98 B	27.44%
DHR	32.85	2.29	6.97%	0.79%	$ 121.18 B	14.89%
INMD	10.09	1.33	13.18%	0.00%	$ 879.48 M	23.27%
PHG	22.93	1.96	8.56%	3.26%	$ 25.90 B	5.50%
SYK	32.76	4.76	14.52%	1.21%	$ 109.34 B	13.21%
FMS	11.00	0.74	6.71%	3.57%	$ 12.12 B	4.89%
UHS	6.82	1.36	20.00%	0.47%	$ 10.37 B	8.56%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

BSX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Boston Scientific

Boston Scientific Corp.

Average Investor10 user rating

4.0 (42 people)

United States

47 years

Founded: 1979

1992

Time since IPO - 34 years

36.000

Employees

Boston Scientific Corporation operates in the Healthcare sector, within the Medical Devices industry. The company develops and commercializes minimally invasive technologies used to treat cardiovascular, neurological, urological, gastrointestinal, and chronic pain conditions.

Its portfolio includes:

Coronary and peripheral stents.
Electrophysiology and ablation technologies.
Implantable cardiac devices.
Neuromodulation and spinal cord stimulators.
Endoscopy and urology systems.

Boston Scientific serves hospitals and healthcare providers globally, with the United States representing its largest market.

Performance is influenced by demographic aging, procedure volumes, reimbursement policies, regulatory approvals, competitive device innovation, and hospital capital spending trends.

The company invests in digital health integration, image-guided therapies, and next-generation implantable technologies to support minimally invasive treatment growth.

Boston Scientific Corporation shares trade on the New York Stock Exchange (NYSE) under the ticker BSX.

History and Development

Founded in 1979 in Massachusetts, Boston Scientific initially focused on catheter-based technologies for interventional medicine.

The company went public in 1992, supporting expansion and increased research investment. Growth accelerated through acquisitions that broadened its cardiovascular, electrophysiology, and neuromodulation capabilities.

In recent years, Boston Scientific has expanded its structural heart and neuromodulation franchises, strengthened global distribution, and navigated healthcare system changes while maintaining focus on innovation and procedural growth in minimally invasive therapies.

Additional Information

Boston Scientific Corp. (United States) is listed on the NYSE and has a market capitalization of $80.09 Billions, with shareholders equity totaling $-.

The company employs approximately 36.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Boston Scientific Corp. reported $20.62 Billions in revenue, generating net income of $3.57 Billions.

Key financial metrics include a P/E ratio of 22.46, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BSX.

Market cap

$ 80.09 Billions

Net worth

$ -

Assets

$ -

Total Shares Outstanding

1.49 Billion

1,485,000,000

Average Daily Trading Volume

$ 16.65 Millions

$ 16,651,223.06

Sector

Health

Industry

Medical Supplies and Equipment

BSX

revenue by Business Segment Boston Scientific

Revenue by Region Boston Scientific

BSX revenue and profits

Financial Results BSX

DRAG THE FRAME TO SEE MORE DATA

BSX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 90.55 40,16% (12M)

P/E

39.31

2.94%

ROE

3.78%

P/BV

1.48

CI - Cigna

$ 288.06 --11,31% (12M)

P/E

10.52

2.11%

ROE

16.97%

P/BV

1.79

CNC - Centene

$ 55.96 --10,88% (12M)

P/E

-4.27

0.00%

ROE

-29.93%

P/BV

1.28

HUM - Humana

$ 274.96 12,29% (12M)

P/E

29.20

1.29%

ROE

6.06%

P/BV

1.77

LLY - Eli Lilly

$ 948.45 26,67% (12M)

P/E

33.59

0.66%

ROE

81.01%

P/BV

27.21

HCA - HCA Healthcare

$ 435.19 24,09% (12M)

P/E

14.35

0.68%

ROE

-228.14%

P/BV

-32.73

NVS - Novartis

$ 146.03 36,97% (12M)

P/E

20.60

2.12%

ROE

34.77%

P/BV

7.16